Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Haloperidol discontinuation for schizophrenia

Esta versión no es la más reciente

ver la versión actual 21 abril 2019

Información

DOI:
https://doi.org/10.1002/14651858.CD011408Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 16 diciembre 2014see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Esquizofrenia

Copyright:
  1. Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Adib Essali

    Correspondencia a: Manaaki Centre, Waikato District Health Board, Thames, New Zealand

    [email protected]

    [email protected]

  • Khaled Turkmani

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Shaimaa Aboudamaah

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Alaa AbouDamaah

    Damascus Health Unit, Damascus University, Damascus, Syrian Arab Republic

  • Mohammad Reyad Dia'a Aldeen

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Mohamad Essam Marwa

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

  • Nawar AlMounayer

    Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic

Contributions of authors

All authors contributed to writing this protocol and approved the final version.

Sources of support

Internal sources

  • Association for Evidence‐based Medicine, Damascus, Syrian Arab Republic.

    Training on writing Cochrane reviews, and ongoing support

  • Manaaki Centre, Waikato District Health Board, Thames, New Zealand.

  • Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.

  • Damascus Health Unit, Damascus University, Damascus, Syrian Arab Republic.

External sources

  • No sources of support supplied

Declarations of interest

All authors have no known conflict of interest.

Acknowledgements

We are grateful to the Association for Evidence‐based Medicine (http://www.a4ebm.org/) for the training courses on conducting systematic reviews and for the ongoing support.
The Cochrane Schizophrenia Group Editorial Base in Nottingham produces and maintains standard text for use in the Methods section of their reviews. We have used this text as the basis of what appears here and adapted it as required.

The search term was developed by the Trials Search Co‐ordinator of the Cochrane Schizophrenia Group, Farhad, and the contact author of this protocol.

We would like to thank Farooq Naeem and Shuo Xiang for peer reviewing this protocol.

Version history

Published

Title

Stage

Authors

Version

2019 Apr 21

Haloperidol discontinuation for people with schizophrenia

Review

Adib Essali, Khaled Turkmani, Shaimaa Aboudamaah, Alaa AbouDamaah, Mohammad Reyad Diaa Aldeen, Mohamad Essam Marwa, Nawar AlMounayer

https://doi.org/10.1002/14651858.CD011408.pub2

2014 Dec 16

Haloperidol discontinuation for schizophrenia

Protocol

Adib Essali, Khaled Turkmani, Shaimaa Aboudamaah, Alaa AbouDamaah, Mohammad Reyad Dia'a Aldeen, Mohamad Essam Marwa, Nawar AlMounayer

https://doi.org/10.1002/14651858.CD011408

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.